Cellerant Therapeutics Inc
Biotechnology company · San Carlos, California, United States
Cellerant Therapeutics Inc is a biotechnology company headquartered in San Carlos, California, United States. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $6.8 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2019.
Cellerant Therapeutics at a glance
What does Cellerant Therapeutics do?
US government research funding
10 SBIR/STTR small-business research awards from US health agencies, $6.8 million in total (2003 to 2018). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $6.5 million sold (2019).
Frequently asked questions about Cellerant Therapeutics
Where is Cellerant Therapeutics headquartered?
Cellerant Therapeutics Inc is headquartered in San Carlos, California, United States.
What does Cellerant Therapeutics do?
Cellerant Therapeutics Inc is a biotechnology company.
Similar companies
- Vaxcyte, Inc.San Carlos, California, United States
- Iovance Biotherapeutics, Inc.San Carlos, California, United States
- Alessa Therapeutics, Inc.San Carlos, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.